Connect with us

China

VIDEO: Sara Carter Rips FBI regarding Hunter Biden, Russia probe

Published

on

Screen Shot 2019 01 16 at 11.08.09 AM

Fox News contributor Sara Carter criticized the FBI over its handling of its investigations into Hunter Biden and President Donald Trump, as well as Special Counsel Robert Mueller’s Russia probe, in a Wednesday night interview on the Fox News commentary and opinion program “Lou Dobbs Tonight.”

This comes off the heels of President-elect Joe Biden‘s son confirming Wednesday that a grand jury has been investigating his taxes and alleged money laundering.

RELATED: Hunter Biden confirms federal investigation into his tax affairs

The FBI, Carter said during the latter half of the over-four-minute segment, “slowed down the investigation prior to the election because they did’t want to interfere in the election.”

The conservative political commentator then dove into comparing the FBI’s activities in 2015 and 2016 to how she says it is presently.

“That didn’t seem to be the FBI’s mantra during 2016 and 2015, when they were going crazy over investigating […] then-candidate Donald Trump and [a] false story about the Russia hoax,” Carter continued. “That didn’t seem to be a problem then. Now what we’re seeing, though, is a very serious charge that also includes money laundering, Lou, and I think that Hunter Biden […] has a lot more problems on his hand[s],” she said, then referencing Biden’s laptop that the FBI had acquired as part of an investigation in 2019.

RELATED: Fox News: Laptop connected to Hunter Biden was part of FBI money laundering probe in 2019

“And remember, Tony Bobulinski—we can’t forget that,” she added, mentioning Hunter Biden’s former business partner that has alleged Biden engaged in corruption and illegal financial dealings during his time on the board of a corrupt Ukrainian energy company called Burisma while his father, then-Vice Joe President Biden, was the public faces of the Obama administration’s policy toward Ukraine.

RELATED: Bobulinski exposes alleged Biden corruption in tell-all interview with Tucker Carlson

Also during the interview, she and Dobbs’ other guest, former U.S. Army Special Forces member Jim Hanson, discussed Rep. Eric Swalwell (D-Calif.) finding himself in hot water this week for reportedly having ties to a suspected Chinese spy, broken by Axios in a bombshell report on Tuesday.

RELATED: Report: Suspected Chinese Spy Developed Relationships with U.S. politicians, including California Rep. Swalwell

RELATED: Kevin McCarthy asks for Swalwell to be ‘removed from congress’

You can follow Douglas Braff on Twitter @Douglas_P_Braff.

You may like

Continue Reading

China

China Says It’s Ready for Monkeypox and the West Isn’t

Published

on

China

As the Western press is becoming more and more concerned with monkeypox outbreaks, a recent bombshell report shows that Wuhan Institute of Virology (WIV) in China manipulated monkeypox to be more contagious in humans. This follows more evidence that the WIV had been experimenting with bat coronaviruses to increasingly infect humans.

But rather than agree to an honest investigation into the WIV and its role in spreading contagion around the world, China is once again trying to sell us an alternative reality. According to Chinese state-run media, it is China that is once again poised to be humanity’s savior and darling when it comes to fighting monkeypox, much like COVID-19. Not only that, but CCP press reporting shows evidence of China having an eerily well advanced infrastructure and gameplan to fight monkeypox. The West in contrast is not prepared, according to China.

Claim #1: China has the Wisdom to Fight Monkeypox

First, Chinese state-run media portray China as in a good position to combat monkeypox due to wisdom gleaned from combating COVID-19 and smallpox. One Global Times article noted that “[i]n the very early stage of the COVID-19 pandemic, China has taken the measures of ‘early identification, reporting, isolation, diagnosis and treatment.’ Under such guidance, China has become one of the most successful countries in the COVID fight.” Another Global Times article cites a World Health Organization official as stating that “China’s COVID-19 control measures in place and largely reduced international arrivals minimize the risks of contagion in China.” A third Global Times article, citing “experts,” claims that “China’s successful experience in eliminating smallpox would also help the country act if monkeypox enters China’s borders…”

Claim #2: Chinese Healthcare Infrastructure Is Well Prepared to Deal with Monkeypox

China is well ahead of the game in dealing with monkeypox, according to Chinese state-run media. Chinese experts “suggest preparation of testing and treatment capacities in advance” to proactively combat monkeypox, according to Global Times. And “drug research should start early so that China can still control [monkeypox] should it assume pandemic proportions,” according to China Daily.

China is apparently quite far along in this “preparation” and “research.”

There are “several” Chinese manufacturers that have already made monkeypox nucleic acid test kits, and that these “can be quickly put into mass production and on the domestic market once approved by the government,” according to a second Global Times article.  This article also states that Chinese manufacturer Liferiver Bio-Tech has a nucleic acid test that has already been ordered in China and abroad.

This same article also states that vaccine development faces “no technological problems” and a vaccine can be produced in China in a year if China’s drug administration administers “a rapid special review.” China’s CDC also has already stockpiled “millions” of doses of smallpox vaccine, produced “an emergency response technical plan on monkeypox, stocked monkeypox detection reagents, and conducted training on monkeypox nucleic acid PCR testing for provincial and municipal CDC professionals.”

Mirroring its earlier “mask diplomacy” for COVID-19, it looks like China is beginning to export its healthcare to the world to help combat monkeypox. China’s Sansure Biotech is ready to register its nucleic acid test kit for monkeypox abroad, according to Global Times. And Jiangsu Bioperfectus Technologies has already has its Monkeypox Virus Real Time PCR Kits in the international market, according to Global Times.

Claim #3: The West is Ill-Equipped to Handle Monkeypox

On the other hand, Chinese media portrays the West as ill-equipped to handle monkeypox. For example, according to one Global Times editorial, “[t]he COVID pandemic that killed more than 1 million people in the US has given a tragic lesson to the US and the West, but it still remains to be seen to what extent the US and the West learned from it.” The West’s “conspiracy theories” and “panic” contributed to the “Western countries’ poor response to COVID-19.” That CCP editorial also pontificates that “[i]t is hoped that Western countries hit by monkeypox can do a good job in responding to the outbreak. They should not misjudge the virus with outdated perceptions…”

Claim #4: Current Monkeypox spread originated from outside China

Chinese media avoids the possibility that this current monkeypox outbreak could have originated in China. One Global Times article claims that there have been no cases of monkeypox reported in China, and that China faces a threat from monkeypox due to the cases being “outside known epidemic areas of Africa.” The fact that many countries have now lifted bans against international travel is the culprit for increased risk of monkeypox transmission, according to anonymous source within the Chinese CDC as mentioned in that same article. Another Global Times article stated that China could quarantine inbound international travellers “if necessary.”

The CCP propaganda machine is at it again.  Much like it tries to portray itself as a leader in fighting COVID-19, China is beginning to run a similar propaganda campaign for monkeypox. China is using COVID-19, and increasingly now monkeypox, as vehicles to curry favor and deflect responsibility for spreading contagion around the world, and to grow markets for healthcare technology and supplies.

You may like

Continue Reading
Advertisement

Trending Now

Advertisement

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC